Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abciximab in Carotid Endarterectomy
NCT00178451Phase 2Withdrawn
- Sponsor
- University of Rochester
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of abciximab in carotid artery stenosis, sponsored by University of Rochester. Status: withdrawn.
02
Drugs
abciximab
03
Conditions
carotid artery stenosis
Beyond the preview
Go deeper on NCT00178451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00178451.